Drug developer Tesaro explores sale
Cancer drug developer Tesaro Inc is exploring a sale and is working with financial advisers after receiving takeover interest, Bloomberg reported on Friday, citing people familiar with the matter. Shares…
Arena Pharma soars on deal with United Therapeutics for hypertension drug
Shares of Arena Pharmaceuticals Inc jumped nearly 30 percent after the drug developer sold rights to develop and sell its hypertension treatment to United Therapeutics Corp, fetching it $800 million…
Post GST, pharma sector grew 6 percent till May-end: Mansukh Mandaviya
After the implementation of GST, the pharmaceutical sector grew 6 per cent to Rs 1,31,312 crore on a year-on-year basis till May 31, Minister of State for Chemicals and Fertilisers…
Dangerous Misuse Of Antibiotics, WHO warned
WHO ( World Health Organization) shared warning about the misuse of antibiotics as WHO mapped the consumption graph and it is dangerously high in many of the countries while a…
Patients and industry fret over drug supplies, if no Brexit deal
By Ben Hirschler Consumers and the pharmaceuticals industry alike are anxious about medicine supplies, if there is no deal on Britain’s departure from the European Union. While the EU and…
Zydus Cadila gets USFDA nod for leukemia treatment injection
New Delhi: Zydus Cadila Wednesday said it has received approval from the US health regulator to market Arsenic Trioxide injection, used to treat a type of leukemia. Zydus Cadila has…
Nifty Pharma index rises; Lupin, Cipla shares shine
NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday. Shares of Lupin (up 1.64 per…
Bayer profit flat as weak animal health offsets strong Xarelto
By Ludwig Burger FRANKFURT: Bayer’s adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and…
Cipla’s subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
Drug major Cipla Tuesday said its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around…
Aurobindo Pharma shares fall 3% after Q2 earnings
New Delhi: Shares of Aurobindo Pharma Tuesday fell almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit for the quarter ended September 30,…
